Modulating phenotype and cytokine production of leucocytic retinal infiltrate in experimental autoimmune uveoretinitis following intranasal tolerance induction with retinal antigens

British Journal of Ophthalmology

Volumn 83, Issue 4, 1999, Pages 478-485

  Laliotou, Barbara ^a   Dick, Andrew D ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; MESSENGER RNA;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; INTRANASAL DRUG ADMINISTRATION; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; RETINA; T LYMPHOCYTE; UVEORETINITIS;

EID: 0032927964     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.83.4.478     Document Type: Article

References (36)

1. Rizzo LV, Caspi RR. Immunotolerance and prevention of ocular autoimmune disease. Curr Eye Res 1995;14:854-64.
2. Caspi RR, Roberge FG, McAllister CG, et al. T cell lines mediating experimental autoimmune uveoretinitis (EAU) in the rat. J Immunol 1986;136:928-33.
3. Forrester JV, Liversidge J, Dua HS, et al. Comparison of clinical and experimental uveitis. Curr Eye Res 1990;9:75-84.
4. Gery I, Mochizuki M, Nussenblatt RB. Retinal specific antigens and immunopathogenic processes they provoke. Progr Retinal Res 1986;5:75-109.
5. Nussenblatt RB, Caspi RR, Mahdi R, et al. Inhibition of S-Ag induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-Ag. J Immunol 1990;144:1689-95.
6. Dick AD, Cheng YF, McKinnon A, el al. Nasal administration of retinal antigens suppresses the inflammatory response in experimental allergic uveoretinitis. Br J Ophthalmol 1993;77:171-5.
7. Nussenblatt RB, Gery I, Weiner HL, et al. Treatment of uveitis by oral administration of retinal antigens: results of a phase I/II randomised masked trial. Am J Ophthalmol 1997;123:583-92.
8. Gregerson DS, Obstrisch WF, Donoso LA. Oral tolerance in experimental autoimmune uveoretinitis: distinct mechanisms of resistance are induced by low zone versus high zone feeding protocols. J Immunol 1993;151:5751-61.
9. Metzler B, Wraith DC. Inhibition of experimental autoimmune encephalomyeliris by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity, Int Immunol 1993;5:1159-65.
10. Melamed DAF. Direct evidence for anergy in T lymphocytes tolerised by oral administration of ovalbumin. Eur J Immunol 1993;23:935-42.
11. Khoury SJ, Hancock WW, Weiner HL. Oral tolerance to myelin basic protein and and natural recovery from experimental autoimmune encephalomyelitis are associated with down regulation of inflammatory cytokines and differential upregulation of trnasforming growth factor beta, inter-leukin 4 and prostaglandin E expression in the brain. J Exp Med 1992;176:1355-64.
12. Dick AD, Cheng YF, Liversidge J, et al. Immunomodulation of experimental autoimmune uveoretinitis: a model of tolerance induction with retinal antigens. Eye 1994;8:52-9.
13. Bai XF, Shi FD, Xiao BG, et al. Nasal administration of myelin basic protein prevents relapsing experimental autoimmune encephalomyelitis in DA rats by activating regulatory cells expressing IL-4 and TGF-beta mRNA. J Neuroimmunol 1997;80:65-75.
14. Myers LK, Sever JM, Stuart JM, et al Suppression of murine collagen-induced arthritis by nasal adminiatration of collagen. Immunology 1997;90:161-4.
15. Shi FD, Bai XF, Li HL, et al. Nasal tolerance in experimental autoimmune my asthenia gravis (EAMG): induction of protective tolerance in primed animals. Clin Exp Immunol 1998;111:506-12.
16. Tian J, Atkinson MA, Clare-Salzer M, et al. Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J Exp Med 1996;183:1561-7.
17. Dick AD, Cheng YF, Liyersidge J, et al. Intranasal administration of retinal antigens suppresses retinal antigeninduced experimental autoimmune uveoretinitis. Immunology 1994;82:625-31.
18. Laliotou B, Liyersidge J, Forrester JV, et al. Interphotoreceptor retinoid binding protein is a potent tolerogen in Lewis rat: suppression of experimental autoimmune uveoretinitis is retinal antigen specific. Br J Ophthalmol 1997;81:1-7.
19. Chen Y, Inobe JI, Kuchroo VK, et al. Oral tolerance in myelin basic protein T cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Proc Natl Acad Sci USA 1996;93:388-91.
20. Bai XF, Li HL, Liu JQ, et al. Complexities of applying nasal tolerance induction as a therapy for ongoing relapsing experimental autoimmune encephalomyelitis (EAE) in DA rats. Clin Exp Immunol 1998;111:205-10.
21. Thurau SR, Chan CC, Nussenblatt RB, et al. Oral tolerance in a murine model of relapsing experimental autoimmune uveoretinitis (EAU): induction of protective tolerance in primed animals, Clin Exp Immunol 1997;109:370-6.
22. Dick AD, Kreutzer B, Laliotou B, et al. Effects of mycophenolate mofetil on nasal mucosal tolerance induction. Invest Ophthalmol Vis Sci 1998;3: 835-10.
23. Kreutzer B, Laliotou B, Cheng Y, et al. Nasal antigen administration of retinal antigens maintains immuosuppression of uveoretinitis in cyclosporin A treated Lewis rats: future treatment of endogenous posterior uveoretinitis. Eye 1997;11:445-5.
24. Barton K, Lightman S. T lymphocyte effector mechanisms in the retina in posterior uveitis. Eye 1994;8:60-5.
25. Dick AD, Duncan L, Hale G, et al. Neutralizing TNF-alpha activity modulates T cell phenotype and function in experimental autoimmune uveoretinitis. J Autoimmun 1998 ;11:255-64.
26. Dick AD, McMenamin PG, Korner H, et al. Inhibition of tumour necrosis factor activity minimises target organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic to the retina. Eur Immunol 1996;26:1018-25.
27. Wolvers DA, van der Cammen MJ, Kraal G. Mucosal tolerance is associated with, but independent of, up-regula lion Th2 responses. Immunology 1997;92;328-33.
28. Prussin C, Metcalfe D. Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anticytokine antibodies. J Immunol Meth 1995;188:117-28.
29. Forrester JV, Huitinga I, Lumsden L, et al. Marrow-derived activated macrophages are required during the effector phase of experimental autoimmune uveoretinitis in rats. Curr Eye Res 1998;17:426-37.
30. Hoey S, Grabowski PS, Ralston S, et al. Nitric oxide accelerates the onset and increases the severity of experimental autoimmune uveoretinitis through an IFN-γ dependent mechanism, J Immunol 1997;159:5132-42.
31. Powrie FDM. Ox22high CD4+ T cells induce wasting disease with multiple organ pathology; prevention of the OX-22low subset. J Exp Med 1990;172: 1701-8.
32. Huitinga I, van Rooijen N, de Groot CJA, et al. Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J Exp Med 1990;172:1025-33.
33. Caspi RR, Chan CC, Fujino Y, et al. Recruitment of antigen-nonspecific cells plays a pivotal role in the pathogenesis of a T cell-mediated organ-specific autoimmune disease, experimental autoimmune uveoretinitis. J Neuro immunol 1993;47:177-88.
34. Laliotou B, Duncan L, Dick AD. Intranasal administration of retinal antigens induces transient T cell activation and apoptosis within drainage lymph nodes but not spleen. J Autoimmun 1999 (in press).
35. Yotsukura J, Huang H, Singh AK, et al. Regulatory cells generated by testicular tolerization to retinal S-Antigen: possible involvement of IL-4, IL-10 and TGF-beta in the suppression of experimental autoimmune uveoretinitis. Cell Immunol 1997;182:89-98.
36. D'Orazio TJ, Niederkorn JY. A novel role for TGF-beta and IL-10 in the induction of Immune privilege. J Immunol 1998;160:2089-98.